Koers Radiko Holdings Corp. Canadian Securities Exchange
Aandelen
JUJU
CA75034R1029
Farmaceutische producten
Omzet 2018 | 107K 146K 98,33K | Omzet 2019 | 5,18 mln. 7,08 mln. 4,78 mln. | Marktkapitalisatie | 6,17 mln. 8,43 mln. 5,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -5,47 mln. -3,69 mln. | Nettowinst (verlies) 2019 | -10 mln. -13,67 mln. -9,23 mln. | EV/omzet 2018 | 101 x |
Nettoschuld 2018 | 259K 354K 239K | Nettoschuld 2019 | 1,98 mln. 2,71 mln. 1,83 mln. | EV/omzet 2019 | 1,57 x |
K/w-verhouding 2018 |
-1,5
x | K/w-verhouding 2019 |
-0,53
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 96,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-19 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Robert Yosaitis
BRD | Director/Board Member | - | 12-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,18% | 723 mld. | |
+32,22% | 598 mld. | |
-2,18% | 364 mld. | |
+20,08% | 331 mld. | |
+3,14% | 288 mld. | |
+16,60% | 244 mld. | |
+9,77% | 210 mld. | |
-5,15% | 208 mld. | |
+8,80% | 169 mld. |